Alto Neuroscience, Inc.
ANRO
$2.22
-$0.06-2.63%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 168.23M | 181.70M | 193.12M | 205.90M | 82.55M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.08M | 1.55M | 2.14M | 2.27M | 522.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 30.00K | 277.00K | 148.00K | 150.00K | 2.32M |
| Total Current Assets | 169.34M | 183.53M | 195.41M | 208.31M | 85.39M |
|
|
|||||
| Total Current Assets | 169.34M | 183.53M | 195.41M | 208.31M | 85.39M |
| Net Property, Plant & Equipment | 7.70M | 7.58M | 1.44M | 1.55M | 1.23M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 504.00K | 504.00K | 504.00K | 58.00K | 6.00K |
| Total Assets | 177.54M | 191.61M | 197.36M | 209.92M | 86.63M |
|
|
|||||
| Total Accounts Payable | 1.58M | 2.25M | 1.84M | 2.41M | 1.07M |
| Total Accrued Expenses | 7.56M | 7.52M | 5.68M | 4.07M | 3.50M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 870.00K | 4.25M | 2.32M | 1.20M | 125.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 320.00K | 916.00K |
| Total Other Current Liabilities | -- | -- | -- | 320.00K | 916.00K |
| Total Current Liabilities | 10.01M | 14.02M | 9.84M | 8.01M | 5.61M |
|
|
|||||
| Total Current Liabilities | 10.01M | 14.02M | 9.84M | 8.01M | 5.61M |
| Long-Term Debt | 11.56M | 6.63M | 7.74M | 8.81M | 9.86M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.52M | 4.62M | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 1.30M | -- | -- | -- |
| Total Liabilities | 26.08M | 26.56M | 17.58M | 16.82M | 15.47M |
|
|
|||||
| Common Stock & APIC | 289.96M | 288.34M | 286.28M | 283.57M | 5.37M |
| Retained Earnings | -138.40M | -123.20M | -106.41M | -90.38M | -76.97M |
| Treasury Stock & Other | -101.00K | -95.00K | -89.00K | -84.00K | -79.00K |
| Total Common Equity | 151.46M | 165.05M | 179.78M | 193.10M | -71.67M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | 141.48M |
| Preferred Stock, Others | -- | -- | -- | -- | 1.35M |
| Total Preferred Equity | -- | -- | -- | -- | 142.83M |
|
|
|||||
| Total Common Equity | 151.46M | 165.05M | 179.78M | 193.10M | -71.67M |
| Total Preferred Equity | -- | -- | -- | -- | 142.83M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 151.46M | 165.05M | 179.78M | 193.10M | 71.16M |
|
|
|||||